99 related articles for article (PubMed ID: 6517423)
1. [Efficacy and reversible nephrotoxicity of cefsulodin during treatment of septicemia from Pseudomonas aeruginosa infection of a pacemaker].
Penalba C; Girard PM; Cremieux AC; Michelet C; Saimot AG; Kernbaum S
Ann Med Interne (Paris); 1984; 135(7):519-22. PubMed ID: 6517423
[TBL] [Abstract][Full Text] [Related]
2. Cefsulodin for the treatment of Pseudomonas infections--a study comparing cefsulodin and ticarcillin.
van der Meer JW; Matze-van der Lans A; Mattie H
Neth J Med; 1989 Jun; 34(5-6):233-42. PubMed ID: 2671757
[TBL] [Abstract][Full Text] [Related]
3. [In vivo-acquired resistance to cefsulodin by a strain of Pseudomonas aeruginosa].
Jouvenot M; Michel-Briand Y; Dupont MJ; Cattin J
Pathol Biol (Paris); 1984 May; 32(5):426-8. PubMed ID: 6429615
[TBL] [Abstract][Full Text] [Related]
4. Combination of cefmenoxime and cefsulodin in the treatment of complicated urinary tract infections caused by Pseudomonas aeruginosa.
Doi T; Nishiura T; Deguchi K; Kondo M
Chemotherapy; 1986; 32(3):299-304. PubMed ID: 3458567
[TBL] [Abstract][Full Text] [Related]
5. Pseudomonas aeruginosa--biology, immunology, and therapy: a cefsulodin symposium. Monterey, California, May 16-17, 1983.
Rev Infect Dis; 1984; 6 Suppl 3():S603-774. PubMed ID: 6443762
[No Abstract] [Full Text] [Related]
6. Pacemaker pocket infection associated with septicemia caused by Pseudomonas aeruginosa.
Nandhakumar B; Menon T; Ravishankar G; Shanmugasundaram S
Int J Infect Dis; 2008 Jan; 12(1):107-8. PubMed ID: 17587621
[No Abstract] [Full Text] [Related]
7. [Pseudomonas aeruginosa bacteriaemia: new clinical and therapeutic aspects ].
Janbon F; Despaux E; Lepeu G; Jonquet O; Santoni A; Balmayer B; Bertrand A
Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):563-7. PubMed ID: 6812007
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of Pseudomonas infections in children with cefsulodin (author's transl)].
Rosenkranz A
Wien Med Wochenschr; 1981 Oct; 131(20):511-4. PubMed ID: 7314634
[TBL] [Abstract][Full Text] [Related]
9. Gentamicin and cefsulodin efficacy in a rat abscess model.
Rubinstein E; Dreznik Z; Mark Z
Surg Gynecol Obstet; 1982 Sep; 155(3):363-8. PubMed ID: 6810484
[TBL] [Abstract][Full Text] [Related]
10. Cefsulodin therapy for infections due to Pseudomonas aeruginosa in patients with burns.
Heimbach DM
Rev Infect Dis; 1984; 6 Suppl 3():S744-50. PubMed ID: 6443775
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy of Pseudomonas aeruginosa pyelonephritis in neutropenic mice with human antilipopolysaccharide monoclonal antibody and cefsulodin.
Ishibashi K; Yamaguchi O; Shiraiwa Y; Ogihara M; Shigeta S
J Urol; 1996 Jun; 155(6):2094-7. PubMed ID: 8618343
[TBL] [Abstract][Full Text] [Related]
12. Predictors of response to therapy for infections caused by Pseudomonas aeruginosa.
Platt R
Rev Infect Dis; 1984; 6 Suppl 3():S759-68. PubMed ID: 6571340
[TBL] [Abstract][Full Text] [Related]
13. Contaminated pacemaker lead wire. Causing chronic pseudomonas septicemia.
Klevan D; Zinneman HH; Hall WH; Sako Y
Minn Med; 1973 Sep; 56(9):750-2. PubMed ID: 4730043
[No Abstract] [Full Text] [Related]
14. Experience with cefsulodin therapy for lower respiratory tract infections caused by Pseudomonas aeruginosa in adults without cystic fibrosis or granulocytopenia.
Nichols L; Gudmundsson S; Maki DG
Rev Infect Dis; 1984; 6 Suppl 3():S711-20. PubMed ID: 6443772
[TBL] [Abstract][Full Text] [Related]
15. Cefsulodin therapy for osteomyelitis due to Pseudomonas aeruginosa.
Pottage JC; Karakusis PH; Trenholme GM
Rev Infect Dis; 1984; 6 Suppl 3():S728-33. PubMed ID: 6443773
[TBL] [Abstract][Full Text] [Related]
16. [Cefsulodin, a new antibiotic of the group of cephalosporins: its action on Pseudomonas aeruginosa (author's transl)].
Segura C; Foz A; Fuster C; Tirado M; Roy C
Med Clin (Barc); 1981 Jun; 77(2):50-5. PubMed ID: 6798336
[TBL] [Abstract][Full Text] [Related]
17. [Clinical application of cefsulodin to Pseudomonas aeruginosa infections in the surgical field (author's transl)].
Tanimura H; Mukaihara S; Hikasa Y; Hajiro A; Takenada M; Maki Y; Nakajima K; Henmi K; Nio Y; Kikuchi S; Hamagaki H; Sugimoto S; Kobayashi M; Matsukawa Y; Masuda K; Yasumoto H; Usui H
Jpn J Antibiot; 1981 Apr; 34(4):459-65. PubMed ID: 7289036
[TBL] [Abstract][Full Text] [Related]
18. [Cefsulodine concentrations in cerebral ventricles during parenteral treatment of ventriculitis due to Pseudomonas aeruginosa (author's transl)].
Veyssier P; Dusehu E
Nouv Presse Med; 1981 Oct; 10(35):2881-2. PubMed ID: 7290939
[TBL] [Abstract][Full Text] [Related]
19. Cefsulodin treatment for serious Pseudomonas aeruginosa infections.
Routman A; Van Manen W; Haddad R; Pollock B; Holmes B; Mogabgab WJ
J Int Med Res; 1986; 14(5):242-53. PubMed ID: 3770290
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study of cefsulodin on Pseudomonas aeruginosa infections in otorhinolaryngology].
Makishima K; Nakashima T; Toriya Y; Murata Y; Watanabe H; Kannae S
Jpn J Antibiot; 1982 Dec; 35(12):2835-8. PubMed ID: 7182538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
